CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.700
- +0.020+2.94%
15min DelayMarket Closed Nov 18 16:00 ET
34.32MMarket Cap-666P/E (TTM)
0.700High0.680Low13.00KVolume0.680Open0.680Pre Close8.86KTurnover1.35052wk High0.03%Turnover Ratio49.02MShares0.50052wk Low-1.05EPS TTM30.83MFloat Cap40.250Historical HighLossP/E (Static)44.04MShs Float0.300Historical Low-1.05EPS LYR2.94%Amplitude--Dividend TTM-350.00P/B1Lot Size--Div YieldTTM
About Helix BioPharma Corp Company
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.
Company Profile
SymbolHBP
Company NameHelix BioPharma Corp
Founded1995
MarketTSE
Employees10
Fiscal Year Ends07-31
Address40 Temperance Street Suite 2700, Bay Adelaide Centre - North Tower
CityToronto
CountryCAN
Zip CodeM5H0B4
Phone+1 604 684-2181
Company Executives
- Name
- Position
- Salary
- Jacek Antas
- Director and Chief Executive Officer
- --
- Praveen K. Varshney, C.F.A.,F.C.A.
- Chief Financial Officer and Corporate Secretary
- --
- Christof Boehler
- Chief Business Development Officer
- --
- Dr. Srikanth Sola
- Chief Strategy Officer and Interim Chief Medical Officer
- --
- Malgorzata Laube
- Independent Director
- --
- Janusz Grabski
- Independent Director
- --
- Jerzy Leszczynski
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data